XTX Topco Ltd - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 85 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2021$21,000
-50.0%
34,476
-17.1%
0.01%
-14.3%
Q3 2021$42,00041,5990.01%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$3,107,0001.71%
ETF MANAGERS GROUP, LLC 14,138,998$8,534,0000.17%
Ikarian Capital, LLC 948,526$584,0000.09%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 318,668$196,0000.03%
Platform Technology Partners 45,000$28,0000.01%
XTX Topco Ltd 34,476$21,0000.01%
PINNACLE ASSOCIATES LTD 947,083$583,0000.01%
Penserra Capital Management LLC 537,236$330,0000.01%
Mirae Asset Global Investments Co., Ltd. 4,070,006$2,506,0000.01%
Tekla Capital Management LLC 154,310$95,0000.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders